Artificial intelligence and machine‑learning methods are optimizing biosimilar design, analytics, and production to cut costs and boost consistency https://www.einpresswire.com/article/833505102/biosimilars-and-biologics-market-growth-driven-by-patent-expiries-innovation-datam-intelligence